Showing results (31-40 of 63) with videos related to
Sort By:
Pageof 7
Journal of Psychopharmacology (Oxford, England)|October 18, 2017
The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorderMark J Niciu, Nicolas D Iadarola, Dipavo Banerjee, et al.Translational Psychiatry|March 7, 2019
Correction: Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depressionWei Guo, Rodrigo Machado-Vieira, Sanjay Mathew, et al.Translational Psychiatry|December 16, 2018
Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depressionWei Guo, Rodrigo Machado-Vieira, Sanjay Mathew, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 9, 2021
Deep transcriptome sequencing of subgenual anterior cingulate cortex reveals cross-diagnostic and diagnosis-specific RNA expression changes in major psychiatric disordersNirmala Akula, Stefano Marenco, Kory Johnson, et al.Nature Genetics|January 19, 2010
Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1Francis J McMahon, Nirmala Akula, Thomas G Schulze, et al.Biorxiv : the Preprint Server for Biology|September 16, 2024
A conserved cell-type gradient across the human mediodorsal and paraventricular thalamusAnton Schulmann, Ningping Feng, Pavan K Auluck, et al.Proceedings of the National Academy of Sciences of the United States of America|March 3, 2015
Rare variants in neuronal excitability genes influence risk for bipolar disorderSeth A Ament, Szabolcs Szelinger, Gustavo Glusman, et al.Translational Psychiatry|December 16, 2023
A resource of induced pluripotent stem cell (iPSC) lines including clinical, genomic, and cellular data from genetically isolated families with mood and psychotic disordersSevilla D Detera-Wadleigh, Layla Kassem, Emily Besancon, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 5, 2013
Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapyRichard A Morgan, Nachimuthu Chinnasamy, Daniel Abate-Daga, et al.Neuropsychobiology|May 11, 2010
The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatmentThomas G Schulze, Martin Alda, Mazda Adli, et al.Pageof 7